蔚蓝生物23年报及24年一季报点评：研发驱动市场承托，酶制剂业绩攀高峰

蔚蓝生物（603739.SH）/农林牧渔 证券研究报告/公司点评 2024 年 05 月 09 日 | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...